Globus Medical Completes Acquisition of Nevro Corp.
Deal News | Apr 03, 2025 | Globenewswire
Globus Medical, Inc., a renowned player in the musculoskeletal technology space, has officially completed the acquisition of Nevro Corp., a medical device company specializing in solutions for chronic pain. This acquisition aims to expedite the market penetration of Nevro's advanced medical technology, specifically in the neuromodulation sector, presenting a $2.5 billion market opportunity for Globus Medical. The merger not only enhances Globus Medical's product offerings but also reflects their strategic focus on being a leader in the musculoskeletal and chronic pain treatment market. Upon completion of this acquisition, Nevro's shares were withdrawn from the NYSE, marking a significant transition for the company. Major financial and legal advisory roles were played by Morgan Stanley & Co. and Wyrick Robbins Yates & Ponton LLP for Globus Medical, and BofA Securities, Inc. and Latham & Watkins LLP for Nevro Corp., respectively. The completion of this deal indicates a robust future ahead for Globus Medical, setting new standards in chronic pain treatment solutions.
Sectors
- MedTech
- Healthcare
Geography
- United States – Globus Medical is based in Pennsylvania, and Nevro Corp. is headquartered in California, marking the U.S. as the primary geography of this transaction.
Industry
- MedTech – The article discusses a merger involving Globus Medical, a musculoskeletal technology company, and Nevro Corp., a medical device company specializing in chronic pain management, indicating involvement in the Medical Technology sector.
- Healthcare – Relevant due to the focus on expanding chronic pain treatment solutions, indicating a direct impact on Healthcare outcomes.
Financials
- $2.5 billion – Potential market opportunity unlocked by the acquisition.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Globus Medical, Inc. | Acquiring Company | Company | A leading global musculoskeletal company focused on solving unmet clinical needs. |
| Nevro Corp. | Target Company | Company | A global medical device company focused on solutions for chronic pain treatment. |
| Morgan Stanley & Co. LLC | Financial Advisor | Company | Served as financial advisor to Globus Medical during the acquisition. |
| Wyrick Robbins Yates & Ponton LLP | Legal Advisor | Company | Provided legal advisement to Globus Medical. |
| BofA Securities, Inc. | Financial Advisor | Company | Served as financial advisor to Nevro Corp. in the transaction. |
| Latham & Watkins LLP | Legal Advisor | Company | Provided legal services to Nevro Corp. |